Cargando…
Modulation of heme and tumor vascular oxygenation- a novel strategy for lung cancer therapy
Hypoxia and faulty vasculature are well-known hallmarks of cancer and in addition to being associated with poor prognosis in patients, these hallmarks are also known to contribute to therapy resistance. In recent years, therapeutics that alleviate hypoxia and promote normalization of vasculature are...
Autores principales: | Ghosh, Poorva, Mason, Ralph P., Liu, Li, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718586/ https://www.ncbi.nlm.nih.gov/pubmed/36471789 http://dx.doi.org/10.18632/oncoscience.569 |
Ejemplares similares
-
The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells
por: Dey, Sanchareeka, et al.
Publicado: (2017) -
Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?
por: Hashimoto, Tomoki, et al.
Publicado: (2006) -
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
por: Hooper, Philip L.
Publicado: (2020) -
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
por: Ghosh, Poorva, et al.
Publicado: (2020) -
Oxygen therapy in palliative care
por: Fardy, H John
Publicado: (2016)